Explore evidence

1 per_100Les taux de prévalence des co-infections étaient très faibles, inférieurs à 1 %.

Malico-infections · paludismeHAL · Unilimdocument of 214 observations

67 %Vaccination reduced the risk of infection by 67% during 8 weeks of monitoring.

Malipaludismepublished 2015Science translational medicineeurope_pmcdocument of 2 observations

1 %La prévalence de Plasmodium ovale était inférieure à 1 % quel que soit le type de dépistage.

MalipaludismeHAL · Unilimdocument of 214 observations

Aucun impact de l’intervention communautaire n’a été noté sur l’incidence cumulée du paludisme chez la femme enceinte au Burkina Faso et au Mali.

Burkina Faso · MalipaludismeHAL · Unilimdocument of 302 observations

18 %Une chimio-prévention SP-AQ réduisait indirectement de 18 % le risque de survenue d’anémie sévère chez les enfants de moins de 5 ans.

Malianémie sévèreHAL · Unilimdocument of 113 observations

532 casesTombouctou health district recorded over 532 confirmed COVID-19 cases.

MaliCOVID-19published 2025PLOS global public healtheurope_pmcdocument of 3 observations

100 %The polymerase chain reaction-corrected cure rate was 100%.

Malipaludismepublished 2012The American journal of tropical medicine and hygieneeurope_pmcdocument of 5 observations

20 %20% to 60% of individuals in Africa and Europe carry at least one CYP2C8 allele associated with reduced metabolism and increased adverse event risk of the anti-malarial amodiaquine.

Malipaludismepublished 2024Human genomicseurope_pmcdocument of 3 observations

0.706 per_1000_person_weeksMalaria incidence in the Kidal region was 0.706 cases per 1,000 person-weeks in 2023.

Malipaludismeobserved 2023HAL · Unilimdocument of 80 observations

2 %Thirty-two mutations in known drug resistance markers attained a frequency of at least 2% in the Malian Plasmodium falciparum populations.

Malipaludismepublished 2022Frontiers in geneticseurope_pmcdocument of 5 observations

0.05 %La prévalence des gamétocytes chez les adultes âgés de 25 ans et plus ou de 65 ans et plus était de 0,05 %.

MalipaludismeHAL · Unilimdocument of 214 observations

7 %Zanthoxylum zanthoxyloides était utilisé traditionnellement contre les douleurs liées à la drépanocytose avec une fréquence d'utilisation de 7 %.

MalidrépanocytoseHAL · Unilimdocument of 20 observations

133 per_1000_person-years_at_riskOver a 5-year period, the incidence of clinical malaria was 133 per 1000 person-years at risk in the combined RTS,S/AS01 E and SMC group.

Malipaludismepublished 2024The Lancet. Infectious diseaseseurope_pmcdocument of 12 observationsDOI 10.1016/s1473-3099(23)00368-7

16 joursUne période pré-patente de 16 jours a été signalée pour une souche ouest-africaine de P. malariae.

MalipaludismeHAL · Unilimdocument of 214 observations

97 %The level of Plasmodium falciparum clinical response to Artesunate-Amodiaquine was 97.0% (163/168) of Adequate Clinical and Parasitological Response after molecular correction.

Malipaludismepublished 2021The Journal of parasitologyeurope_pmcdocument of 8 observations

2,407 patientsIn Mali, Cameroon, and Ivory Coast, 2407 sickle cell disease patients aged 3 years old and over were included in the study.

Cameroun · Côte d'Ivoire · Malidrépanocytosepublished 2017Bloodeurope_pmcdocument of 4 observationsDOI 10.1182/blood-2016-12-755777

1.33 IRRModernly Wealth Households (MWH) had an incidence rate ratio of 1.33 for SARS-CoV-2 seropositivity compared to Low-Wealth Households (LWH).

MaliCOVID-19HAL · Unilimdocument of 88 observations

0.37 g/dLConversion from conditional to abnormal TCD was associated with a mean decrease in hemoglobin value of 0.37 g/dL.

Malidrépanocytosepublished 2013BloodOpenAlexdocument of 10 observations

98.18 %HemotypeSC® had a specificity of 98.18% [95% CI: 97.69–98.67] for diagnosing possible sickle cell disease (SCD) compared to high-performance liquid chromatography in a study in Mali, April–August 2021.

Malidrépanocytoseobserved April–August 2021HAL · Unilimdocument of 103 observations

35.5 %In Part B of the trial, Plasmodium falciparum infections were detected on blood-smear examination in 39 participants (35.5%) who received 10 mg of CIS43LS per kilogram.

Malipaludismepublished 2022The New England journal of medicineeurope_pmcdocument of 5 observations

59 %Parmi les 835 patients suspects de COVID-19, 482 (59 %) présentaient des critères majeurs de COVID-19.

MaliCOVID-19observed June 2022 and September 2022HAL · Unilimdocument of 36 observations

Potent inhibition of Plasmodium malariae and Plasmodium falciparum was observed with piperaquine exposure.

Malipaludismepublished 2021The Journal of antimicrobial chemotherapyeurope_pmcdocument of 4 observations

47.3 %The pfcrt-C72V73I74E75T76 haplotype was found in 47.3% of samples.

Malipaludismeobserved 2013 to 2014published 2017Infectious diseases of povertyeurope_pmcdocument of 6 observations

5.64 %Plasmodium malariae était plus fréquent chez les individus asymptomatiques (5,64 % vs. 2,45 %, p < 0,001).

MalipaludismeHAL · Unilimdocument of 214 observations

0.08 %The prevalence of HbC/β-plus-thalassaemia among 3648 newborns in Mali was 0.08%.

MaliHbC/β-plus-thalassaemiaobserved April–August 2021HAL · Unilimdocument of 103 observations